Welcome to CoreTechDev.com, the website of the successful pioneering incubator Core Technology Development Group.
CoreTech is the founding entity that pioneered the following companies
Future Foods: Over $4B in licensed product revenues generated.
ThermGen: Built an environmental breakthrough for remediating hazardous chemicals.
SafeSuite: Lead investor in the award-winning Self-Protective Data
WaterFaire: A newly designed & improved water from air technology
Opportunities for clients and co-venture affiliates
The need after development is the capture of market share. This occurs by either licensing, joint venturing, contracting, or sale. Call about new projects we are incubating now in health, cyber tech, and the environment at 800-4-FUTURE
Next generation of waste destruction, needed for compliance when in metropolitan areas requiring clean emissions.
A proven technology for domestic water backup in case of drought restrictions. Solar powered, highest gal. per dollar technology available where dew points near oceans and lakes are located.
The success of Core Technology
Contact us for more information on our Environmental, Medical and Cyber technologies.
CoreTech is one of the founding investors in the company KeyAvi Data. This pioneering Smart Data technology company won the RSA award as the Best Cyber Security Company in 2021. CoreTech focuses on consumer applications in the fields of medicine, finance, law, engineering, and data rights management.
SafeSuite is the brand that Core Tech will market under, and will be the first to market the Smart Data technology to a variety of clients who have expressed not only interst as well as defined critical needs. Safe Suite will assist with Safe Tokens, Safe Contracts, and Safe Cloud tools for data securing as well as enabling, such as tracking, geo-fencing, time embargo, and a variety of security policies, are now available for customers to use for their key business and personal data.
How it works
What we do best.
Core Technology Development Group Researches, DEVELOPS, and Invests in commerciallly promising, sound scientific breakthroughs.
Founding investor in the original firm with rapid prototype cranial implants for surgical use; using proprietary 3D printing developed by the pioneer and originator of 3D printing software. Profitable since its inception, and steady growth ongoing.
Topical Site Specific delivery of OTC and prescription pharmaceuticals, as well as active nutraceutical ingredients. Based on the need to minimize systemic side effects and guarantee minimal dosing, with targeted delivery to the needed site of activity.